- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Small Cap High Growth Stocks
Global Pharmaceuticals & Biotech Small Cap High Growth Stocks
UPDATED Mar 23, 2024
Companies below a US$500M market cap with strong earnings growth forecasted for the next 3 years.
158 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
688073 | CN¥38.91 | -5.2% | -56.5% | CN¥3.5b | CN¥103.00 | PE31.3x | E48.6% | 2.8% | ||
CKPT | US$1.94 | 1.0% | -47.8% | US$72.1m | US$18.25 | PS700.4x | E81.7% | n/a | ||
ALDX | US$2.90 | 3.9% | -67.9% | US$170.8m | US$9.40 | PB1.4x | E51.9% | n/a | ||
OPTN | US$1.63 | -13.3% | -11.4% | US$183.6m | US$3.75 | PS2.6x | E61.6% | n/a | ||
EVOK | US$0.60 | -2.9% | -73.9% | US$5.1m | US$7.00 | PE-0.7x | E101.6% | n/a | ||
MGTX | US$6.36 | 0.2% | 25.2% | US$408.4m | US$21.60 | PS29.1x | E52.8% | n/a | ||
CAPR | US$6.38 | -0.2% | 54.9% | US$200.3m | US$21.00 | PS8x | E59.4% | n/a | ||
INIT | kr8.98 | 5.6% | 50.2% | kr503.3m | kr24.69 | PB29.4x | E43.4% | n/a | ||
TARSONS | ₹411.65 | 2.7% | -24.7% | ₹22.1b | ₹644.00 | PE40.1x | E31.3% | n/a | ||
2395 | JP¥1,562.00 | 2.7% | -43.5% | JP¥65.0b | JP¥3,650.00 | PE11.8x | E23.2% | 3.2% | ||
IMM | AU$0.39 | 5.5% | 40.0% | AU$457.7m | AU$1.30 | PS116.4x | E62.1% | n/a | ||
ORX | kr14.72 | -3.8% | -1.6% | kr507.1m | kr22.50 | PB8.6x | E75.1% | n/a | ||
4597 | JP¥34.00 | -5.6% | -30.6% | JP¥5.9b | JP¥100.00 | PS9.6x | E64.7% | n/a | ||
BFRI | US$1.20 | -22.6% | -90.3% | US$6.1m | US$16.00 | PB1.3x | E65.8% | n/a | ||
PGEN | US$1.40 | -2.4% | 45.3% | US$347.2m | US$9.00 | PS55.8x | E55.5% | n/a | ||
MDWD | US$15.97 | -0.2% | 31.8% | US$147.8m | US$28.50 | PS7.9x | E61.0% | n/a | ||
HYL | €11.10 | -6.7% | -13.3% | €310.8m | €19.90 | PS110.4x | E103.9% | n/a | ||
TBPH | US$8.92 | 3.2% | -15.2% | US$429.6m | US$14.00 | PS7.5x | E56.8% | n/a | ||
MARI | €19.85 | -3.6% | -46.2% | €30.5m | €66.53 | PS2.7x | E60.1% | n/a | ||
AELIS | €13.45 | 0.7% | -4.7% | €176.6m | €21.33 | PS18x | E29.2% | n/a | ||
CRMD | US$3.92 | 2.9% | 15.0% | US$215.5m | US$13.00 | PB3.1x | E59.6% | n/a | ||
SPPI | US$1.03 | 5.3% | 17.0% | US$209.9m | US$1.26 | PS8.2x | E67.3% | n/a | ||
ALPHE | €2.00 | 2.6% | -53.6% | €14.4m | €5.80 | PS4.6x | E78.8% | n/a | ||
MGRC | RM0.43 | -1.1% | -24.3% | RM59.7m | n/a | PS6.2x | E140.6% | 0% |